R R

What Is Cytoreductive Surgery?

Cytoreductive surgery is an extensive cancer operation designed to remove as much visible tumor as possible, ideally leaving no macroscopic disease when that can be achieved safely. The term is commonly used for cancers that spread across peritoneal surfaces in the abdomen or pelvis. Surgery can include removal of tumor deposits, affected peritoneum, and portions of involved organs. In selected peritoneal malignancies, cytoreductive surgery can be combined with hyperthermic intraperitoneal chemotherapy, or HIPEC.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Cytoreductive Surgery?

Cytoreductive surgery is an extensive cancer operation designed to remove as much visible tumor as possible, ideally leaving no macroscopic disease when that can be achieved safely. The term is commonly used for cancers that spread across peritoneal surfaces in the abdomen or pelvis. Surgery can include removal of tumor deposits, affected peritoneum, and portions of involved organs. In selected peritoneal malignancies, cytoreductive surgery can be combined with hyperthermic intraperitoneal chemotherapy, or HIPEC.

read more about cytoreductive surgery ...

Copy this HTML:

Copy HTML Copied!

Why Is Cytoreductive Surgery Performed?

The procedure is used for carefully selected patients with cancers such as appendiceal, colorectal, ovarian, mesothelioma, or other peritoneal surface malignancies when meaningful tumor reduction appears technically achievable. Complete macroscopic cytoreduction is an important treatment goal because the amount of residual visible disease strongly influences outcomes in many settings. Patient selection considers cancer type, disease distribution, peritoneal cancer burden, involvement of critical structures, performance status, prior treatment, and disease outside the abdomen. Cytoreductive surgery is not suitable when the expected morbidity is too high or when disease cannot be reduced to a meaningful extent.

How Is Cytoreductive Surgery Performed?

The surgeon systematically examines the abdomen and pelvis and removes visible tumor from peritoneal surfaces and involved organs. Procedures can include peritonectomy, bowel resection, omentectomy, splenectomy, hysterectomy, removal of ovaries, or other organ resections depending on where disease is located. The extent is tailored to achieve the greatest safe reduction in macroscopic tumor burden. HIPEC can be delivered afterward in selected diseases by circulating heated chemotherapy through the abdominal cavity before the operation is completed.

What Is Recovery Like After Cytoreductive Surgery?

Recovery is often longer than after a limited cancer operation because cytoreduction can involve several abdominal organs and multiple bowel or peritoneal resections. Patients are monitored for bowel function, pain, nutrition, infection, bleeding, fluid balance, and complications related to any organ removed or reconstructed. Hospital recovery can include drains, temporary nutritional support, intensive physical activity progression, and management of a new stoma when one is required. Long-term follow-up depends on the cancer type and can include systemic therapy, imaging, tumor markers, and surveillance for recurrence.

What Are the Risks and Complications?

Possible complications include bleeding, infection, bowel leak, abscess, bowel obstruction, blood clots, wound problems, and injury to abdominal or pelvic organs. Extensive resections can also cause nutritional problems, altered bowel function, urinary complications, or the need for a temporary or permanent stoma. HIPEC adds potential risks such as bone-marrow suppression, kidney injury, or other chemotherapy-related toxicity depending on the drug used. Because cytoreductive surgery can be highly complex, major complications and reoperation are recognized risks even at specialized centers.

Frequently Asked Questions About Cytoreductive Surgery

Is cytoreductive surgery the same as debulking surgery?

The terms overlap, but cytoreductive surgery often refers to a planned effort to remove all or nearly all visible disease, particularly in peritoneal malignancies. Debulking is a broader term for removing as much tumor as safely possible.

What is HIPEC?

Hyperthermic intraperitoneal chemotherapy is heated chemotherapy circulated inside the abdominal cavity after cytoreductive surgery in selected cancers.

Does cytoreductive surgery remove every cancer cell?

No. Even complete macroscopic cytoreduction removes visible disease, but microscopic cancer cells can remain and can require additional treatment.

Why is complete cytoreduction important?

For many peritoneal malignancies, outcomes are strongly associated with how little visible disease remains after surgery, making completeness of cytoreduction a major treatment goal.

References

Cytoreduction (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). StatPearls (NCBI Bookshelf). https://pubmed.ncbi.nlm.nih.gov/34033325/. Date Accessed September 11, 2026.

Multi-Society Guideline on Cytoreductive Surgery and HIPEC: Methodology and Overview of the Results. PubMed. https://pubmed.ncbi.nlm.nih.gov/39689044/. Date Accessed September 11, 2026.

National Guidelines for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Malignancies: A Worldwide Systematic Review and Recommendations of Strength Analysis. PubMed. https://pubmed.ncbi.nlm.nih.gov/40413333/. Date Accessed September 11, 2026.

Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases. PubMed. https://pubmed.ncbi.nlm.nih.gov/31377856/. Date Accessed September 11, 2026.

Cytoreductive surgery and HIPEC for peritoneal carcinomatosis. A review on morbidity and mortality. PubMed. https://pubmed.ncbi.nlm.nih.gov/26051337/. Date Accessed September 11, 2026.